# MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events

> **NCT05773235** · — · UNKNOWN · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 60 (estimated)

## Conditions studied

- Intracerebral Hemorrhage
- CAA - Cerebral Amyloid Angiopathy
- Cerebral Small Vessel Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Combined 3- and 7 Tesla-MRI

## Key facts

- **NCT ID:** NCT05773235
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05773235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05773235, "MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05773235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*